Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety, Tolerability, and Pharmacokinetics of a Single Escalating Dose and Repeated Doses of CN-105 in Healthy Adult Subjects.
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
CereNova, LLC
Start Date
August 17, 2015
End Date
June 26, 2016
Administered By
School of Medicine
Awarded By
CereNova, LLC
Start Date
August 17, 2015
End Date
June 26, 2016